サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434871

アルファ放出核種市場：放射性核種タイプ別、用途別-2024-2030年の世界予測

Alpha Emitters Market by Radionuclide Type (Actinium-225, Americium-241, Astatine-211), Application (Industrial, Medical) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アルファ放出核種市場：放射性核種タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アルファ放出核種市場規模は2023年に8億8,695万米ドルと推定され、2024年には10億6,244万米ドルに達すると予測され、CAGR 20.18%で2030年には32億1,195万米ドルに達すると予測されます。

アルファ放出核種の世界市場

主な市場の統計
基準年[2023］ 8億8,695万米ドル
予測年 [2024] 10億6,244万米ドル
予測年［2030] 32億1,195万米ドル
CAGR（%） 20.18%
アルファ放出核種 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアルファ放出核種市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アルファ放出核種市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アルファ放出核種市場の市場規模および予測は？

2-アルファ放出核種市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アルファ放出核種市場における技術動向と規制の枠組みは？

4-アルファ放出核種市場における主要ベンダーの市場シェアは？

5-アルファ放出核種市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 心臓病やがんの患者数の増加
      • ターゲットを絞ったアルファ線エミッターの潜在的な利点に対する意識の向上
      • 産業分野でのアルファ放出核種の使用法が新たに登場
    • 抑制要因
      • アルファ放出核種の制作コストが高い
    • 機会
      • がん治療のための新たな臨床試験活動の出現
      • アルファ放出核種の新しい応用分野を探索するための継続的な研究開発活動
    • 課題
      • アルファ放出核種の複雑な取り扱いと安全上の問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アルファ放出核種市場放射性核種の種類別

  • アクチニウム-225
  • アメリシウム-241
  • アスタチン-211
  • プルトニウム239
  • ラジウム-226
  • ウラン-238

第7章 アルファ放出核種市場：用途別

  • 産業用
  • 医学
    • 骨転移
    • 内分泌腫瘍
    • 卵巣がん
    • 膵臓がん
    • 前立腺がん

第8章 南北アメリカのアルファ放出核種市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のアルファ放出核種市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのアルファ放出核種市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Actinium Pharmaceuticals, Inc.
    • Alpha Tau Medical Ltd.
    • Bayer AG
    • Bracco S.p.A.
    • Cardinal Health, Inc.
    • Eckert & Ziegler
    • Fusion Pharmaceuticals Inc.
    • Ionetix Corporation
    • Niowave Inc.
    • Orano Group
    • RadioMedix, Inc.
    • Siemens Healthineers
    • Telix Pharmaceuticals Limited
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ALPHA EMITTERS MARKET RESEARCH PROCESS
  • FIGURE 2. ALPHA EMITTERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALPHA EMITTERS MARKET DYNAMICS
  • FIGURE 7. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALPHA EMITTERS MARKET SIZE, BY ASTATINE-211, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALPHA EMITTERS MARKET SIZE, BY PLUTONIUM-239, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ALPHA EMITTERS MARKET SIZE, BY RADIUM-226, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALPHA EMITTERS MARKET SIZE, BY URANIUM-238, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 16. ALPHA EMITTERS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ALPHA EMITTERS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ALPHA EMITTERS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ALPHA EMITTERS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ALPHA EMITTERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 148. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 149. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. ALPHA EMITTERS MARKET LICENSE & PRICING
目次
Product Code: MRR-742BD517A955

[185 Pages Report] The Alpha Emitters Market size was estimated at USD 886.95 million in 2023 and expected to reach USD 1,062.44 million in 2024, at a CAGR 20.18% to reach USD 3,211.95 million by 2030.

Global Alpha Emitters Market

KEY MARKET STATISTICS
Base Year [2023] USD 886.95 million
Estimated Year [2024] USD 1,062.44 million
Forecast Year [2030] USD 3,211.95 million
CAGR (%) 20.18%
Alpha Emitters Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alpha Emitters Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alpha Emitters Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alpha Emitters Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Alpha Tau Medical Ltd., Bayer AG, Bracco S.p.A., Cardinal Health, Inc., Eckert & Ziegler, Fusion Pharmaceuticals Inc., Ionetix Corporation, Niowave Inc., Orano Group, RadioMedix, Inc., Siemens Healthineers, and Telix Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Alpha Emitters Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Radionuclide Type
    • Actinium-225
    • Americium-241
    • Astatine-211
    • Plutonium-239
    • Radium-226
    • Uranium-238
  • Application
    • Industrial
    • Medical
      • Bone Metastasis
      • Endocrine Tumors
      • Ovarian Cancer
      • Pancreatic Cancer
      • Prostate Cancer
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alpha Emitters Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alpha Emitters Market?

3. What are the technology trends and regulatory frameworks in the Alpha Emitters Market?

4. What is the market share of the leading vendors in the Alpha Emitters Market?

5. Which modes and strategic moves are suitable for entering the Alpha Emitters Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Alpha Emitters Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of patients with cardiac and cancer ailments
      • 5.1.1.2. Increased awareness of potential benefits of targeted alpha emitter
      • 5.1.1.3. Emerging use of alpha emitters in industrial sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of alpha emitters
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging new clinical trial activities for cancer treatment
      • 5.1.3.2. Ongoing R&D activities for exploring new application areas of alpha emitters
    • 5.1.4. Challenges
      • 5.1.4.1. Complex handling and safety hazards of alpha emitters
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Alpha Emitters Market, by Radionuclide Type

  • 6.1. Introduction
  • 6.2. Actinium-225
  • 6.3. Americium-241
  • 6.4. Astatine-211
  • 6.5. Plutonium-239
  • 6.6. Radium-226
  • 6.7. Uranium-238

7. Alpha Emitters Market, by Application

  • 7.1. Introduction
  • 7.2. Industrial
  • 7.3. Medical
    • 7.4.1. Bone Metastasis
    • 7.4.2. Endocrine Tumors
    • 7.4.3. Ovarian Cancer
    • 7.4.4. Pancreatic Cancer
    • 7.4.5. Prostate Cancer

8. Americas Alpha Emitters Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Alpha Emitters Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Alpha Emitters Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Actinium Pharmaceuticals, Inc.
    • 12.1.2. Alpha Tau Medical Ltd.
    • 12.1.3. Bayer AG
    • 12.1.4. Bracco S.p.A.
    • 12.1.5. Cardinal Health, Inc.
    • 12.1.6. Eckert & Ziegler
    • 12.1.7. Fusion Pharmaceuticals Inc.
    • 12.1.8. Ionetix Corporation
    • 12.1.9. Niowave Inc.
    • 12.1.10. Orano Group
    • 12.1.11. RadioMedix, Inc.
    • 12.1.12. Siemens Healthineers
    • 12.1.13. Telix Pharmaceuticals Limited
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing